News

CHICAGO--(BUSINESS WIRE)--Errant Gene Therapeutics (“EGT”) announces that the New York Supreme Court Justice Barry Ostrager sanctioned Bluebird Bio, Inc. (“Bluebird”) and rejected Bluebird ...
CHICAGO--(BUSINESS WIRE)--Errant Gene Therapeutics (“EGT”) announces, that on April 30, 2020, the New York Supreme Court, First Department, Appellate Division unanimously affirmed rulings in ...